Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India
NCT05994820 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2058
Last updated 2024-03-01
Summary
The goal of this clinical trial is to learn compare the efficacy Chatbot messaging directed to parents of infants and children living in unstable urban housing (UUH) in Varansi, India. The main questions it aims to answer are: 1) Can a Chatbot intervention be used to improve attitudes towards childhood vaccines? 2) Does an intervention in which vaccination is presented in the larger context of well-being improve attitudes towards vaccination?
Conditions
- Vaccine Hesitancy
Interventions
- BEHAVIORAL
-
Happy Baby Programme -Vaccine Campaign
The Happy Baby Programme is a WhatsApp based Chatbot designed to promote childhood vaccination in Hindi.
- BEHAVIORAL
-
Happy Baby Programme- Vaccine ++ Campaign
The Happy Baby Programme is a WhatsApp based Chatbot designed to promote childhood vaccination in Hindi as part of a holistic healthy baby approach that includes nutrition and sanitation.
Sponsors & Collaborators
-
Johns Hopkins Bloomberg School of Public Health
lead OTHER
Principal Investigators
-
Rajiv N Rimal, PhD · Johns Hopkins University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-09-26
- Primary Completion
- 2024-02-10
- Completion
- 2024-02-10
Countries
- India
Study Locations
More Related Trials
-
The Efficacy of Digital Educational Interventions on Parental HPV Knowledge and Attitude, and Their Children's Vaccination Rates
NCT06341738 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants
NCT01421121 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants
NCT03128489 ·Status: WITHDRAWN ·Phase: PHASE3
-
Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age
NCT01470287 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study on Combined Immune Effect of EV71 Inactivated Vaccine
NCT03519568 ·Status: UNKNOWN ·Phase: PHASE4
-
Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014
NCT00614614 ·Status: COMPLETED ·Phase: PHASE3
-
Vaccine Social Media Randomized Intervention Trial
NCT01873040 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants
NCT01098474 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine,Recombinant (Hansenula Polymorpha)
NCT05916326 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older
NCT04648241 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children and Infants
NCT05189548 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage
NCT03379467 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
NCT01353703 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months Old
NCT02806531 ·Status: UNKNOWN ·Phase: PHASE4
-
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
NCT00463437 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)
NCT04941261 ·Status: UNKNOWN ·Phase: PHASE2
-
Hepatitis B Vaccination in Infants
NCT01896596 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules
NCT00316147 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers
NCT01106092 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
NCT01507857 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants
NCT00480324 ·Status: COMPLETED ·Phase: PHASE3
-
Persistence of IPV Immunity
NCT03723837 ·Status: COMPLETED ·Phase: PHASE4
-
Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians
NCT01777074 ·Status: COMPLETED
-
Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India
NCT00289172 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
NCT00289783 ·Status: COMPLETED ·Phase: PHASE3